Page last updated: 2024-09-03
zk 93426 and zolpidem
zk 93426 has been researched along with zolpidem in 1 studies
Compound Research Comparison
| Studies (zk 93426) | Trials (zk 93426) | Recent Studies (post-2010) (zk 93426) | Studies (zolpidem) | Trials (zolpidem) | Recent Studies (post-2010) (zolpidem) |
|---|---|---|---|---|---|
| 56 | 5 | 2 | 1,825 | 368 | 683 |
Protein Interaction Comparison
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Clayton, T; Cook, JM; Cromer, BA; Ma, C; Majumder, S; Namjoshi, OA; Petrou, S; Platt, DM; Roth, BL; VanLinn, ML; Yin, W | 1 |
Other Studies
1 other study(ies) available for zk 93426 and zolpidem
| Article | Year |
|---|---|
Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse.
Topics: Alcoholism; Animals; Benzodiazepines; Binding Sites; Carbolines; Cell Line; Computer Simulation; GABA-A Receptor Antagonists; Humans; Protein Subunits; Rats; Receptors, GABA-A; Stereoisomerism; Structure-Activity Relationship | 2010 |